News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,472 Results
Type
Article (88189)
Company Profile (825)
Press Release (784438)
Multimedia
Podcasts (206)
Webinars (32)
Section
Business (233351)
Career Advice (4152)
Deals (39896)
Drug Delivery (156)
Drug Development (91478)
Employer Resources (205)
FDA (18438)
Job Trends (17441)
News (398134)
Policy (39997)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (165)
Alliances (56982)
ALS (191)
Alzheimer's disease (1826)
Antibody-drug conjugate (ADC) (379)
Approvals (18639)
Artificial intelligence (684)
Autoimmune disease (200)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (491)
Bladder cancer (176)
Brain cancer (69)
Breast cancer (695)
Cancer (5352)
Cardiovascular disease (474)
Career advice (3579)
Career pathing (43)
CAR-T (318)
CDC (68)
Celiac Disease (2)
Cell therapy (877)
Cervical cancer (40)
Clinical research (77427)
Collaboration (1961)
Company closure (6)
Compensation (1237)
Complete response letters (82)
COVID-19 (3005)
CRISPR (110)
C-suite (970)
Cystic fibrosis (157)
Data (6702)
Decentralized trials (2)
Denatured (76)
Depression (163)
Diabetes (556)
Diagnostics (7330)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (332)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (258)
Earnings (100756)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135890)
Executive appointments (1072)
FDA (21815)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (26)
Funding (1651)
Gene editing (234)
Generative AI (71)
Gene therapy (720)
GLP-1 (1169)
Government (5482)
Grass and pollen (8)
Guidances (389)
Healthcare (20983)
HIV (76)
Huntington's disease (54)
IgA nephropathy (90)
Immunology and inflammation (312)
Immuno-oncology (76)
Indications (134)
Infectious disease (3323)
Inflammatory bowel disease (218)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17971)
IRA (61)
Job creations (5202)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (99)
Layoffs (663)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (20)
Lung cancer (717)
Lymphoma (396)
Machine learning (49)
Management (66)
Manufacturing (927)
MASH (184)
Medical device (15095)
Medtech (15161)
Mergers & acquisitions (23044)
Metabolic disorders (1483)
mRNA (201)
Multiple sclerosis (179)
NASH (23)
Neurodegenerative disease (386)
Neuropsychiatric disorders (108)
Neuroscience (3250)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5124)
Now hiring (70)
Obesity (724)
Opinion (349)
Ovarian cancer (176)
Pain (232)
Pancreatic cancer (253)
Parkinson's disease (317)
Partnered (39)
Patents (548)
Patient recruitment (555)
Peanut (65)
People (67165)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23923)
Phase 2 (33595)
Phase 3 (25313)
Pipeline (6140)
Policy (358)
Postmarket research (3554)
Preclinical (10727)
Press Release (72)
Prostate cancer (273)
Psychedelics (60)
Radiopharmaceuticals (318)
Rare diseases (1021)
Real estate (7445)
Recruiting (81)
Regulatory (29361)
Reports (69)
Research institute (2746)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (278)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4340)
State (2)
Stomach cancer (21)
Supply chain (118)
Tariffs (101)
The Weekly (128)
Vaccines (1193)
Venture capital (103)
Weight loss (495)
Women's health (105)
Worklife (23)
Date
Today (181)
Last 7 days (903)
Last 30 days (3278)
Last 365 days (32852)
2026 (5785)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (355)
Arkansas (15)
Asia (51699)
Australia (9085)
California (12228)
Canada (3476)
China (1234)
Colorado (516)
Connecticut (534)
Delaware (363)
Europe (118973)
Florida (1815)
Georgia (397)
Hawaii (4)
Idaho (68)
Illinois (1022)
India (81)
Indiana (574)
Iowa (24)
Japan (470)
Kansas (135)
Kentucky (49)
Louisiana (35)
Maine (84)
Maryland (1520)
Massachusetts (8973)
Michigan (381)
Minnesota (687)
Mississippi (7)
Missouri (146)
Montana (36)
Nebraska (30)
Nevada (134)
New Hampshire (88)
New Jersey (3283)
New Mexico (33)
New York (3218)
North Carolina (1689)
North Dakota (10)
Northern California (5913)
Ohio (377)
Oklahoma (23)
Oregon (55)
Pennsylvania (2431)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4740)
Tennessee (193)
Texas (1922)
United States (43988)
Utah (369)
Vermont (1)
Virginia (308)
Washington D.C. (88)
Washington State (1012)
West Virginia (4)
Wisconsin (139)
Wyoming (2)
There are 873,472 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vasomune Therapeutics, Inc., and AnGes, Inc., Announce US FDA Clearance of Investigational New Drug (IND) Application For Pegevongitide (AV-001) Treatment in Resuscitation of Severely Burned Patients
March 4, 2026
·
3 min read
Press Releases
Affinia Therapeutics Granted FDA Fast Track Designation for AFTX-201 as a Treatment for People Living with BAG3-Associated Dilated Cardiomyopathy (DCM)
March 4, 2026
·
4 min read
Press Releases
MIRA Pharmaceuticals Completes Phase 1 Dosing of Ketamir-2
March 4, 2026
·
6 min read
Press Releases
Ablexis Reports 33 AlivaMab(R) Mouse-Derived Human Antibodies Now in Clinical Development, Further Validating AlivaMab Mouse Transgenic Platform
March 4, 2026
·
2 min read
Press Releases
NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs
March 4, 2026
·
9 min read
Press Releases
CervoMed Announces Selection of Formulation and Dosing Regimen for Planned Phase 3 Trial in Patients with Dementia with Lewy Bodies
March 4, 2026
·
8 min read
Press Releases
BridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conference
March 4, 2026
·
2 min read
Press Releases
EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026
March 4, 2026
·
1 min read
Press Releases
Landmark Data Validate BrainsWay’s SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment
March 4, 2026
·
8 min read
Press Releases
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 4, 2026
March 4, 2026
·
1 min read
1 of 87,348
Next
